Own Sonic Healthcare shares? Here's a look at the state of its balance sheet

Fundamentals are becoming increasingly important again in this current investment landscape

| More on:
Doctor reading a file

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Sonic is a healthcare giant that has built up a bastion of cash and assets over the years 
  • With the probability of economic risks increasing, we take a closer look at Sonic's balance sheet
  • In the last 12 months, the Sonic share price has slipped around 12%

The Sonic Healthcare Ltd (ASX: SHL) share price had a turbulent time in FY22. After surging to 52-week highs of $46.71 on 30 December, the company's shares then cratered to $32.22 by 8 March.

After a relief rally, Sonic was trading sideways until June, but has since walked back towards its yearly lows, as seen below.

TradingView Chart

The forward-looking climate demands more from companies in terms of cash (liquidity and working capital) management.

With that in mind, let's take a look at Sonic's balance sheet to gain some insight into how it might weather any potential economic storm.

Sonic balance sheet breakdown

The most recent snapshot of Sonic's financial health was supplied within its set of half-yearly accounts back in February.

At that time, the company had cash and marketable securities of $735.3 million, down 18% from the previous year.

Shareholder equity totalled $7.26 billion, made up of $12.5 billion in total assets and $5.24 billion in total liabilities.

Let's take a deeper dive into how Sonic is managing cash and working capital.

Sonic should meet its short-term obligations when they fall due. Short-term liabilities are covered 1.1x by short-term assets (current ratio). That's one check for the Sonic Healthcare share price.

Meanwhile, the ratio of debt to assets is 26%, meaning debt holders have financed Sonic's asset base by that amount.

The long-term debt to total capital ratio is 28% suggesting the company has low leverage. It also has around $1 billion in long-term lease obligations.

Further insights to consider for the Sonic share price

Linking the balance sheet with some figures on the income statement gives further insights.

Sonic turned over its inventory 6.3 times in H1 FY22 and generated 75 cents for every dollar invested into its asset base.

It also generated a 12% return on assets and return on invested capital of 16% for the half as well. This is well above the company's cost of capital of 7%.

From this data, we can make a few inferences. First, Sonic can cover its short-term obligations when they come due.

It also is lowly-leveraged, with debt making up less than 30% of its capital structure. That's important in a world of rising interest rates.

It is also generating a decent return on its assets and invested capital that is above what it costs to acquire that capital.

These could be defensible characteristics in the event of an economic downturn. Remember, the balance sheet illustrates the financial health of the company, and these ratios give further insights.

In the last 12 months, the Sonic share price has slipped 12% into the red.

Sonic's asset and liability growth since 2018 is plotted on the chart below.

TradingView Chart

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Polynovo shares fall despite yesterday's upbeat update. Here's what investors are watching

Polynovo shares slide after a solid update as investors wait for clearer growth signals.

Read more »

Woman flexes muscles after donating blood.
Healthcare Shares

Check out this CSL share price forecast for 2026. It's hard to believe!

RBC Capital Markets thinks CSL is a bargain at current levels.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Good news out of China has this drug company's shares higher

A major new market will open up following this approval.

Read more »